Discussing the benefits of deeper and broader stimulation using BrainsWay's innovative H-Coil technology, as well as comparisons to Figure-8 design.
Samuel Zibman, PhD
BrainsWay
Tue, August 17
11:00 am EDT
Join Key Opinion Leader (KOL) Kimberly Cress, M.D. (Greenbrook TMS NeuroHealth Centers) and BrainsWay's Chief Medical Officer, Dr. Aron Tendler to discuss the current OCD treatment landscape, BrainsWay's Deep TMS™ therapy, and a robust body of clinical evidence.
Kimberly Cress, M.D. and Aron Tendler, M.D.
Greenbrook TMS and BrainsWay
Tue, August 31
11:00 am EDT